PCN116 Cost-Effectiveness of Denosumab Versus Zoledronic Acid (ZA) for the Prevention of Skeletal-related Events (SRE) in Patients with Bone Metastases from Solid Tumors in the Netherlands
Abstract
Authors
M. Lothgren A. Bracco B. Lucius K. Northridge M. Halperin D. Macarios K. Chung M.D. Danese